-- Robert Preidt
THURSDAY, April 14 (HealthDay News) -- Kidney transplant
patients whose immune systems produce antibodies that target the
new organ can develop accelerated narrowing of the arteries that
supply blood to the kidney, which may lead to organ rejection.
That's the finding of a study by researchers in France who
examined kidney biopsies from 99 kidney transplant patients -- 40
with antibodies targeting their new kidney and 59 without the
Significant progression of arteriosclerosis in kidney arteries
during the three to 12 months after transplant occurred in the
antibody-positive patients, but not in the antibody-negative
patients. The rate of artery narrowing, or arteriosclerosis, in the
antibody-negative patients was about one-third that seen in the
The rate of arteriosclerosis in the antibody-positive patients
was much worse than expected and translated into about 28 years of
"aging" of the new kidney in the first year after transplantation,
the researchers said in an American Society of Nephrology news
"This accelerated arteriosclerosis can now be seen to form part of the rejection process, and it will probably be found to contribute to the ultimate decline of kidney function," said study author Dr. Gary Hill, of the Georges Pompidou European Hospital in Paris.
The study appears in an upcoming issue of the
Journal of the American Society of Nephrology.
The findings highlight the importance of arteriosclerosis
following a kidney transplant, the researchers said.
The National Kidney Foundation has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.